When: Sustained close above $385 on volume >8M with MACD extension

Then: Rebuild toward Overweight at 25-30% starter position

When: Adverse ruling or trial date confirmation

Then: Exercise put-spread

HOLD — do not deploy fresh capital at current levels; wait for pullback to $369 or below before adding; use stop at $354 only if position is established at planned entry

• Three consecutive quarters of declining operating margins: Q1 FY26 68.3%, Q2 67.4%, Q3 63.5% — lowest trailing-five-quarter margin by 330 basis points
• Revenue grew 14.3% YoY but EPS only grew 10.4% — operating leverage breaking down, not building
• Failed breakout at $385.57 on Aug 26 (8.48M volume), rejected again at $384.20 next session with 4.63M volume (45% volume drop) — declining participation, not healthy consolidation
• Bollinger upper band at $386.07 acting as resistance, stock 1.2% below this level
• Buybacks executing at 32.5x trailing earnings; forward P/E of 25.4x is sell-side consensus that can be revised lower
• Bear case in fundamentals report prices Visa at $280 to $310 — 19% drawdown from current levels is a plausible base case, not a tail risk
• Ackman 13F filing is already fully reflected in price; acting now means paying full price for a thesis already established
• Stablecoin optionality: market pricing 94% odds it does not materialize in meaningful way in next 18 months; direct revenue impact in 2026 is incremental noise
• Asymmetric risk-reward: bull case $420 requires multiple expansion, consensus to hold, and no macro shock; bear case $280–$310 requires only one thing to go wrong
• ATR of 1.7%; stock 6.6% above 50 SMA at $357.94; pullback to 10 EMA at $375.88 alone is a 1.5% move well within normal daily range
• Stock ran from $311 to $381 in three months — a 22% gain where easy money has already been made
• Aug 17 session saw stock drop to deep negative MACD on 15.5M shares volume — gap risk below $354 is real given hawkish Fed, Jackson Hole headlines, or Q4 earnings miss scenario

→ vs aggressive: Dismissed 330 basis points of Q3 margin compression as 'sequential noise from rebate timing and agentic-commerce investment' — no confirmed explanation exists; three consecutive quarters of decline cannot be explained away by a single quarter's timing effects

→ vs aggressive: Framed declining volume at all-time highs as 'healthy consolidation' — actually a failed breakout with 45% volume decline on second rejection of $385 level, a technical warning signal

→ vs aggressive: Conflated forward P/E (25.4x consensus) with trailing earnings multiple (32.5x) at which buybacks execute; treats 28% forward EPS growth as a contract rather than a forecast that can be cut, especially given recent margin under-delivery

→ vs aggressive: Cited Ackman/Pershing Square 13F filing as a signal to follow — information is already fully reflected in price by the time retail and smaller funds can act on it; 22% gain in three months before filing date means buying 'the back of the train'

→ vs aggressive: Treats stablecoin optionality (6% odds per Polymarket) as a reason to add capital now — 94% base case is that this does not materialize in any meaningful way in next 18 months; optionality is a reason to hold, not to size up at all-time highs

→ vs aggressive: Calculated 1.4-to-1 reward-to-risk on $381 entry with $354 stop — this ignores gap risk on a single-name $712B mega-cap; Aug 17 session shows stops can be punched through on macro events; requires multiple things to go right for bull case vs. only one for bear case

→ vs aggressive: Argued they 'may never get a $369 entry' — this constructs an implausible scenario of no 1.5% to 3.3% pullback in a $712B name over several weeks; the 10 EMA at $375.88 represents a normal 1.5% pullback within ATR; this is arguing against gravity

HOLD with scaled entry framework: 25-33% of incremental capital at $375-378, additional tranches at $369 and $358-360; tighten trailing stop to $373-375; set invalidation if V closes below $354 weekly; use Q4 FY26 earnings as margin validation point

• Both aggressive and conservative analysts agree on the core HOLD decision; dispute is only on optionality for adds
• Scaled entry approach recommended rather than all-or-nothing on single price level
• Q3 390 bps margin compression breaks prior trend pattern (Q1-Q2 was only 90 bps), suggesting event-driven rather than structural compression
• Bear case of $280-310 is a stacked scenario (30% multiple compression + earnings cut + macro turn), not a base case
• Ackman signal confirms long-term thesis but is not a timing signal for current entry decisions
• $369 target for tier-1 adds is too rigid given ATR of 1.7% and 6.6% above 50-day moving average
• Consider position sizing review—current position may be oversized at elevated technical levels
• Macro backdrop is permissive but not a catalyst that justifies paying 32.5x trailing multiple
• MACD histogram showing +1.24 to +1.20 indicates first hint of deceleration in 5-session uptrend
• Conservative analyst's 61% ROE and 15% earnings growth makes buybacks at 25x forward mathematically accretive, but forward earnings can be cut

→ vs aggressive: Hold-and-Add at $381.60 after 22% gain in 3 months at 32.5x trailing is a momentum bet, not a moderate path; MACD histogram ticked down from +1.24 to +1.20 showing first deceleration signal

→ vs conservative: Bear case pricing ($280-310) is a stacked tail outcome requiring simultaneous margin compression, earnings cuts, and macro deterioration—not a base case; Q3 margin compression breaks the prior trend pattern